A Modular Antigen-Anchoring Strategy for Cellular Nanoparticle Vaccines Against Burkholderia pseudomallei
ACS Nano · 18.08.2026 · 20 (32) · 22919-22930
DOI: 10.1021/acsnano.6c09441 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 06.08.2026. Verfasst von Nishta Krishnan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California92093, United States. Hauptthemen laut MEDLINE: Burkholderia pseudomallei, Antigens, Bacterial, Nanoparticles, Bacterial Vaccines. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Defense Threat Reduction Agency.
Abstract (Originalsprache)
A challenge in vaccine engineering is the lack of adaptable platforms that allow rapid formulation of complex, multiantigen vaccines while preserving antigen stability, orientation, and immunological function. Here, we report a plug-and-play biomimetic nanovaccine platform based on cellular nanoparticles (CNPs) that enables rapid and chemically defined antigen assembly via a modular antigen-anchoring strategy. In this approach, protein and polysaccharide antigens are independently conjugated to lipid anchors through click chemistry and spontaneously inserted into the membrane of preformed CNPs, thereby decoupling antigen functionalization from nanoparticle fabrication and enabling combinatorial design without reengineering the nanocarrier. Using B. pseudomallei antigens (Hcp1 and CPS) as a representative example, we show that the resulting antigen-displayed CNPs exhibit controlled surface presentation, preserved antigen orientation, and strong physicochemical stability. This modular assembly enhances dendritic cell uptake, maturation, and cytokine production and promotes efficient activation of antigen-presenting cells in draining lymph nodes. Importantly, the platform elicits concurrent CD4+ and CD8+ T-cell responses together with high-titer, high-avidity antibody responses and germinal center formation, demonstrating its ability to drive coordinated adaptive immunity. Collectively, this work establishes a versatile and rapidly deployable framework for nanovaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, California92093, United States.
- Department of Microbiology and Immunology, University of Nevada, Reno School of Medicine, Reno, Nevada89557, United States.
- Los Alamos National Laboratory , Los Alamos, New Mexico87545, United States.
ORCID-Profile: Emily Lam, Jacob J Hoenig, Oliver Nizet, Jessica Z Kubicek-Sutherland, Liangfang Zhang
Förderung
- Defense Threat Reduction Agency
Zitieren
APA
Krishnan, N., Mohapatra, A., Lam, E., Wilkinson, E. L., Urbano-Munoz, F., Hoenig, J. J., Lee, J., Nizet, O., Lee, A. Y., Fang, R. H., Gao, W., McMahon, B. H., Kubicek-Sutherland, J. Z., Burtnick, M. N., Brett, P. J., & Zhang, L. (2026). A Modular Antigen-Anchoring Strategy for Cellular Nanoparticle Vaccines Against Burkholderia pseudomallei. ACS Nano, 20(32), 22919-22930. https://doi.org/10.1021/acsnano.6c09441
Vancouver
Krishnan N, Mohapatra A, Lam E, Wilkinson EL, Urbano-Munoz F, Hoenig JJ, et al. A Modular Antigen-Anchoring Strategy for Cellular Nanoparticle Vaccines Against Burkholderia pseudomallei. ACS Nano. 2026;20(32):22919-22930. doi:10.1021/acsnano.6c09441
BibTeX
@article{Krishnan2026,
author = {Krishnan, Nishta and Mohapatra, Animesh and Lam, Emily and Wilkinson, Elizabeth L and Urbano-Munoz, Federico and Hoenig, Jacob J and Lee, Junyong and Nizet, Oliver and Lee, Adam Y and Fang, Ronnie H and Gao, Weiwei and McMahon, Benjamin H and Kubicek-Sutherland, Jessica Z and Burtnick, Mary N and Brett, Paul J and Zhang, Liangfang},
title = {A Modular Antigen-Anchoring Strategy for Cellular Nanoparticle Vaccines Against Burkholderia pseudomallei},
journal = {ACS Nano},
year = {2026},
volume = {20},
number = {32},
pages = {22919--22930},
doi = {10.1021/acsnano.6c09441}
}
EUVIMED